O uso dos bifosfonatos como adjuvantes no tratamento das doenças periodontais: uma revisão de literatura

Authors

  • Júlia Beatriz Moreira de Souza
  • Bianca Dutra Aguiar Madeira
  • Nara Lhays Teixeira Nunes Parente
  • Valdelya Nara Pereira Aguiar
  • Ana Cristina Bevilaqua Batista Pedroza
  • José Carlos Silva Júnior
  • Luzia Hermínia Teixeira de Sousa
  • João Victor Menezes do Nascimento

DOI:

https://doi.org/10.34119/bjhrv9n1-079

Keywords:

bifosfonatos, doença periodontal, terapia adjuvante, osteonecrose

Abstract

A doença periodontal é uma condição inflamatória crônica multifatorial, caracterizada pela destruição progressiva dos tecidos de suporte dentário e pela perda óssea alveolar, configurando um importante desafio terapêutico na prática odontológica contemporânea. Diante da participação ativa da resposta imunoinflamatória do hospedeiro e do desequilíbrio entre os processos de reabsorção e formação óssea, terapias adjuvantes capazes de modular esses mecanismos têm sido investigadas, com destaque para os bifosfonatos, em razão de sua ação antirreabsortiva e potencial efeito anti-inflamatório. Nesse contexto, esta revisão teve como propósito analisar o uso dos bifosfonatos como agentes adjuvantes no tratamento das doenças periodontais, considerando seus efeitos clínicos e os riscos associados à sua aplicação. Foi realizada uma revisão integrativa da literatura nas bases de dados PubMed e Biblioteca Virtual em Saúde (BVS), utilizando os descritores “Bisphosphonates”, “Periodontal Disease” e “Treatment”, combinados pelo operador booleano AND. Após a aplicação dos critérios de elegibilidade e leitura na íntegra, nove estudos compuseram a amostra final. Os achados indicaram que bifosfonatos como o alendronato e o ácido zoledrônico apresentam efeitos osteoprotetores e anti-inflamatórios, com redução de mediadores inflamatórios, incluindo IL-1β, TNF-α e MMP-8, além de influência positiva sobre o sistema RANK/RANKL/OPG e melhora de parâmetros clínicos periodontais, especialmente quando utilizados por via tópica. Por outro lado, o uso sistêmico em doses elevadas foi associado ao risco de osteonecrose dos maxilares, reforçando a necessidade de cautela na indicação clínica. Dessa forma, os bifosfonatos despontam como uma alternativa adjuvante promissora na terapia periodontal, desde que empregados de maneira criteriosa e respaldados por evidências clínicas adicionais que confirmem sua segurança e eficácia a longo prazo.

References

ALWITHANANI, N. Role of Bisphosphonates in Periodontal Diseases: Systematic Review. Journal of Pharmacy & Bioallied Sciences, v. 15, n. 1, p. 46-53, 2023.

BALTA, M. G. et al. Host modulation and treatment of periodontal disease. Journal of Dental Research, v. 100, n. 8, p. 798-809, 2021.

BUDUNELI, Nurcan et al. Calcium and vitamin D supplements with or without alendronate and supragingival calculus formation in osteoporotic women: a preliminary study. Expert Opinion on Pharmacotherapy, v. 9, n. 12, p. 2015-2020, 2008.

CARVALHO, Paulo Sérgio Perri de et al. Principais aspectos da cirurgia bucomaxilofacial no paciente sob terapia com bifosfonatos. RFO UPF, v. 15, n. 2, p. 183-189, 2010.

CHATZOPOULOS, Georgios S; KOIDOU, Vasiiiki P; TSALIKIS, Lazaros. Local drug delivery in the treatment of furcation defects in periodontitis: a systematic review. Clinical Oral Investigations. V.27, n.3, p.955-970, 2023.

DIOGUARDI, M. et al. Complications of oral bisphosphonate-induced osteonecrosis in patients undergoing tooth extraction: a systematic review and literature updates. European Journal of Medical and Pharmacological Sciences, v. 27, n. 13, p.6359-6373, 2023.

EL-MA’AITA, Ahmad et al. Awareness of the risk of developing medication-related osteonecrosis of the jaw among bisphosphonate users. Journal of International Medical Research, v. 48, n. 9, 2020.

FIORILLO, Luca et al. Impact of bisphosphonate drugs on healing of dental implants and peri-implant hard and soft tissues: a systematic review. BMC Oral Health, v. 22, n. 1, p. 291, 2022.

FURLANETO, Flávia A C et al. Local administration of Tiludronic Acid downregulates important mediators involved in periodontal tissue destruction in experimental periodontitis in rats. Archives of Oral Biology, vol. 88, 2018.

GEHRKE, Bárbara et al. Long-term consequences of bisphosphonate therapy for osteoporosis. Archives of Endocrinology and Metabolism, v. 68, p. 1-8, 2024.

GOBIN, Romila et al. Periodontal diseases and the risk of metabolic syndrome: An updated systematic review and meta-analysis. Frontiers in Endocrinology, v. 11, n. 336, 2020.

GUPTA, Shikha et al. Clinical efficacy of amino bisphosphonate on periodontal disease status in postmenopausal women: a randomized double-blind placebo- controlled trial. Journal of Family Medicine and Primary Care, v. 9, n. 9, p. 4919- 4924, 2020.

HELMI, Mohammad et al. Annual alveolar bone loss in older adults taking oral bisphosphonate: a retrospective cohort study. BMC Oral Health, vol. 19, p. 260, 2019.

HILTUNENA, Anna K et al. Bioactive glass combined with bisphosphonates provides protection against biofilms formed by the periodontal pathogen Aggregatibacter actinomycetemcomitans. International journal of pharmaceutics, vol. 501, p.1-2, 2016.

KAWAHARA, Mampei; KUROSHIMA, Shinichiro; SAWASE, Takashi. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review. International journal of implant dentistry, v. 7, n. 1, p. 47, 2021.

KOIDE, Yoko et al. Effect of systemic administration of bisphosphonates in patients with periodontal disease: a systematic review and meta-analysis protocol. BMJ Open, v. 12, n. 3, 2022.

KWOEN, Min-Jeong et al. Association between periodontal disease, tooth extraction, and medication-related osteonecrosis of the jaw in women receiving bisphosphonates: A national cohort-based study. Journal of periodontology, v.94, n.1, 2023.

LAFORGIA, Alessandra et al. Therapeutic strategies and genetic implications for periodontal disease Management: A Systematic Review. International Journal of Molecular Sciences, v. 25, n. 13, 2024.

LANDI, L. et al. Antiresorptive therapy in osteometabolic patients affected by periodontitis. A joint position paper of the Italian Society of Orthopedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP). Journal of Orthopaedics and Traumatology, v. 24, n. 1, p. 36, 2023.

LI, Chun Lei et al. Impact of Actinomyces naeslundii on bisphosphonate-related osteonecrosis of the jaws in ovariectomized rats with periodontitis. Journal of Cranio-Maxillo-Facial Surgery, vol. 43, p.1662, 2015.

MOTTA, Luiza dos Anjos et al. Efeito de bifosfonatos de uso local no tratamento de periodontite crônica: revisão de literatura. Publicações em Odontologia, v. 17, n.1, p. 1-10, 2023.

MUNIZ, Francisco Wilker Mustafa Gomes et al. Effect of adjuvant bisphosphonates in the treatment of periodontitis: systematic review with meta-analysis. Journal of Oral Biology and Craniofacial Research, v. 11, n. 2, p. 158-168, 2021.

OLIVEIRA, Bruna Silveira de et al. Impacto do uso sistêmico de estatinas e de bisfosfonatos nos tecidos periodontais: revisão narrativa. Revista da Faculdade de Odontologia, Passo Fundo, v. 28, n. 1, p. 50-68, 2023.

ORTARZEWSKA, Martyna et al. Periodontal disease in patients with thyroid disease: a systematic review with meta-analysis. Advances in Medical Sciences, v. 69, n. 2, p. 289-295, 2024.

OZDEN, Feyza Otan et al. Effect of bisphosphonate as an adjunct treatment for chronic periodontitis on gingival crevicular fluid levels of nuclear factor-κB ligand (RANKL) and osteoprotegerin in postmenopausal osteoporosis. Journal of Oral Science, v. 59, n. 1, p. 147-155, 2017.

OZDEN, Feyza Otan et al. Effects of periodontal and bisphosphonate treatment on the gingival crevicular levels of sclerostin and dickkopf-1 in postmenopausal osteoporosis with and without periodontitis. Journal of Periodontal Research, vol. 57, n. 4, p. 849-858, 2022.

PATILA, Vathsala et al. Awareness of medication-related osteonecrosis of the jaw among dental professionals: a multicenter study. Oral health and preventive dentistry, v.18, n.3, p.505-509, 2020.

SANTOS, Gabriela Dias Rosso dos; CORRÊA, Luciana; CARVALHO, Danielle Lima Corrêa de. Mandibular osteonecrosis associated with bisphosphonates in the treatment of rheumatoid arthritis. Revista Gaúcha de Odontologia, São Paulo, v. 72, 2024.

SCHWECH, Nurda; NILSSON, Johanna; GABRE, Pia. Incidence and risk factors for drug-related osteonecrosis after tooth extraction in cancer patients: A systematic review. Clinical and Experimental Dental Research, v. 9, n. 1, p. 55-65, 2022.

SILVA, Maria Eduarda Mello Costa da; PAVAN, Priscila. Uso adjunto de bifosfonato no tratamento periodontal. Ciência Atual, Rio de Janeiro, v. 22, n. 1, p. 1353-1365, 2025.

SOUSA, Fátima Regina Nunes de et al. Effect of high concentration of zoledronic acid on induced tooth movement and its impact on root, periodontal ligament and alveolar bone tissues in rats. Scientific Reports, v. 11, n. 1, 2021.

SOUTOME, Sakiko et al. Relationship between tooth extraction and development of drug-related osteonecrosis of the jaw in cancer patients. Scientific Reports, v. 11, n. 1, p. 17226, 2021.

TAGUCHI, Akira et al. Improved periodontal disease and prevention of tooth loss in osteoporosis patients receiving once-yearly zoledronic acid: a randomized clinical trial. Menopause. New York, N.Y, vol. 26, n. 11, p. 1277-1283, 2019.

TENÓRIO, Júnior et al. Occurrence of bisphosphonate-associated osteonecrosis of the jaw in individuals with rheumatoid arthritis - a systematic review. Oral Medicine, Oral Pathology and Oral Surgery, v. 29, n. 3, p. 390-397, 2024.

TZSCHENTKE, Thomas M. et al. Pharmacology of bisphosphonates in pain. British Journal of Pharmacology, v. 178, n. 9, p. 1973-1994, 2021.

VILLANUEVA, Maria Cosin et al. Study of microRNAs in gingival crevicular fluid as periodontal disease biomarkers: a systematic review. International Journal of Molecular Sciences, v. 25, n. 15, 2024.

VEGA, Heber Isac Arbildoy et al. Periodontal disease and cardiovascular disease: a comprehensive review. BMC Oral Health, v. 24, p. 1308, 2024.

VERDE, María E et al. Effect of Bisphosphonates on the Levels of Rankl and Opg in Gingival Crevicular Fluid of Patients With Periodontal Disease and Post-menopausal Osteoporosis. Acta Odontologica Latinoamericana, vol. 28, p. 215, 2015.

WASTI, Jyoti; WASTI, Amit; SINGH, Ritunja. Efficacy of antioxidant therapy on progression of periodontal disease – A randomized clinical trial. Indian Journal of Dental Research, v. 32, n. 2, p. 187-191, 2021.

WAYAMA, Marcelo Tadahiro et al. Diminished Progression of Periapical Lesions with Zoledronic Acid in Ovariectomized Rats. Journal of Endodontics, vol. 41, 2015.

ZHANG, Yuhan et al. The relationship between periodontal disease and breast cancer: from basic mechanism to clinical management and prevention. Oral Health & Preventive Dentistry, v. 21, p. 49-60, 2023.

Published

01/19/2026

How to Cite

SOUZA, J. B. M. de; MADEIRA, B. D. A.; PARENTE, N. L. T. N.; AGUIAR, V. N. P.; PEDROZA, A. C. B. B.; SILVA JÚNIOR, J. C.; SOUSA, L. H. T. de; NASCIMENTO, J. V. M. do. O uso dos bifosfonatos como adjuvantes no tratamento das doenças periodontais: uma revisão de literatura. Brazilian Journal of Health Review, [S. l.], v. 9, n. 1, p. e85169, 2026. DOI: 10.34119/bjhrv9n1-079. Disponível em: https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/85169. Acesso em: 20 oct. 2026.

Issue

Section

Original Papers